MedTrace Logo

Ovarian Hyperstimulation Syndrome (OHSS) Prevention With Agonist

NCT00835523 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 51

Last updated 2012-06-14

No results posted yet for this study

Summary

The aim of the study is to explore the concept of GnRH-agonist triggering in combination with elective cryopreservation of all 2PN oocytes at larger scale in a pragmatic clinical setting. The question asked is: "Does GnRH-agonist triggering and cryopreservation work", in terms of efficacy and safety, when applied to a larger cohort of patients, and by a number of different centres with different clinical routines.

Conditions

  • Ovarian Hyperstimulation Syndrome

Sponsors & Collaborators

  • University Hospital Schleswig-Holstein

    lead OTHER

Principal Investigators

  • Georg Griesinger, PD Dr. med. · Department of Obestrics and Gynecology, University Clinic of Schleswig-Holstein, Campus Luebeck

Eligibility

Min Age
18 Years
Max Age
39 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-05-31
Primary Completion
2010-07-31
Completion
2010-07-31

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00835523 on ClinicalTrials.gov